Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately
This study has been completed.
Study NCT01457508 Information provided by GlaxoSmithKline
First Received on October 20, 2011. No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hepatitis B
Diphtheria
Haemophilus Influenzae Type b (Hib)
Poliomyelitis
Pertussis
Tetanus
Additional conditions recognized in this trial
Hepatitis
Hepatitis A
Influenza, Human
Whooping Cough
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Bordetella Infections
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Clostridium Infections
Corynebacterium Infections
Digestive System Diseases
DNA Virus Infections
Enterovirus Infections
Gram-Negative Bacterial Infections
Gram-Positive Bacterial Infections
Hepadnaviridae Infections
Hepatitis, Viral, Human
Infection
Liver Diseases
Myelitis
Nervous System Diseases
Neuromuscular Diseases
Orthomyxoviridae Infections
Picornaviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Spinal Cord Diseases
Virus Diseases
Interventions listed in this trial
DTPa-HBV-IPV/Hib (Infanrix hexa™)
DTPa-HBV-IPV (Infanrix penta™)
Hib (Hiberix™)
Additional drug interventions recognized in this trial
Pentetic Acid
More general drug interventions related to this trial
Antidotes
Chelating Agents
Iron Chelating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Sponsors listed in this trial
GlaxoSmithKline
Back to top of Main Content
